Joint Managing Director Of Bharat Biotech

Rediff.com » News » Joint Managing Director Of Bharat Biotech

News for Joint Managing Director Of Bharat Biotech

News
Business

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......

Padma Bhushan for Indian vaccine makers

Founders of indigenous COVID-19 vaccine developer Bharat Biotech -- Krishna Ella and Suchitra Ella, along with Cyrus Poonawalla, the chairman and MD of another vaccine manufacturer Serum Institute......

Modi meets 7 Covid vaccine manufacturers

Prime Minister Narendra Modi on Saturday met Indian COVID-19 vaccine manufacturers who said his leadership was a key factor in India being able to administer 100 crore doses of the jabs in just......

Bharat Biotech to supply 500 mn Covaxin jabs to Centre

Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme. ......

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is......

Four lessons of change from Tata Communications CEO

Unlike many of his peers in corporate houses, Kumar doesn't have an MBA but says that hardly matters, as he has been lucky to have got great on-the-job experience, such as during his stint in Asia......

Pharma majors open new R&D chapter

USV, a Mumbai-based Rs 800 crore drug manufacturer with research expertise in small molecules and proteins, recently decided to venture into the lucrative segment of vaccines. For that, it decided......

Making of India's genome valley

When the Andhra Pradesh government identified biotechnology as one of the engines of economic growth for the state, it came as a surprise for many. After all, Shantha Biotech and Bharat Biotech......

Hepatitis vaccine proves a bitter business

The Hepatitis-B vaccine market, which is shared by more than 13 players, has not grown beyond Rs 120 crore (Rs 1.2 billion) against the projected Rs 600 crore (Rs 6 billion) by 2004-05.Retail......

Rediff News

Joint Managing Director Of Bharat Biotech

News for Joint Managing Director Of Bharat Biotech

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Padma Bhushan for Indian vaccine makers

Modi meets 7 Covid vaccine manufacturers

Bharat Biotech to supply 500 mn Covaxin jabs to Centre

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Four lessons of change from Tata Communications CEO

Pharma majors open new R&D chapter

Making of India's genome valley

Hepatitis vaccine proves a bitter business

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS